HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fouad Al-Dayel Selected Research

5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- one

3/2012c-Met inhibitor synergizes with tumor necrosis factor-related apoptosis-induced ligand to induce papillary thyroid carcinoma cell death.
12/2011Coexpression of activated c-Met and death receptor 5 predicts better survival in colorectal carcinoma.
1/2011HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fouad Al-Dayel Research Topics

Disease

51Neoplasms (Cancer)
07/2021 - 04/2006
15Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 05/2008
11Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2013 - 08/2006
7Ovarian Epithelial Carcinoma
05/2021 - 09/2009
7Papillary Thyroid Cancer
01/2021 - 07/2008
6Carcinogenesis
05/2021 - 12/2007
6Breast Neoplasms (Breast Cancer)
01/2021 - 07/2007
5Neoplasm Metastasis (Metastasis)
12/2021 - 01/2016
3Lymphatic Metastasis
11/2021 - 01/2021
3Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 09/2009
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2013 - 06/2006
3Lymphoma (Lymphomas)
07/2011 - 12/2007
2Thyroid Neoplasms (Thyroid Cancer)
01/2016 - 07/2008
2Carcinoma (Carcinomatosis)
11/2009 - 11/2009
2Obesity
11/2009 - 09/2009
1Endometrial Neoplasms (Endometrial Cancer)
02/2021
1Turcot syndrome
01/2021
1Triple Negative Breast Neoplasms
01/2021
1Hypertrophy
03/2015
1Cardiomegaly (Heart Hypertrophy)
03/2015

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
11/2021 - 08/2006
6Phosphotransferases (Kinase)IBA
01/2021 - 01/2010
6EnzymesIBA
01/2011 - 12/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2019 - 04/2006
5Bortezomib (Velcade)FDA Link
01/2018 - 05/2008
4Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2010
4Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2011 - 10/2008
4Leptin ReceptorsIBA
07/2010 - 09/2009
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2020 - 01/2010
3embelinIBA
12/2018 - 07/2015
3Protein Kinases (Protein Kinase)IBA
01/2018 - 05/2008
3Cisplatin (Platino)FDA LinkGeneric
05/2015 - 01/2011
35- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
03/2012 - 01/2011
3LigandsIBA
03/2012 - 07/2010
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2011 - 09/2010
3LeptinIBA
03/2010 - 09/2009
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2009 - 12/2006
2B7-H1 AntigenIBA
02/2021 - 01/2021
2Factor V (Coagulation Factor V)IBA
01/2021 - 01/2020
2Estrogen ReceptorsIBA
01/2021 - 01/2021
2IodineIBA
01/2021 - 05/2010
2Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 01/2021
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020 - 01/2018
2MethyltransferasesIBA
01/2019 - 06/2006
2Transcription Factors (Transcription Factor)IBA
03/2015 - 01/2012
2Thiostrepton (Gargon)IBA
07/2012 - 01/2012
2Proto-Oncogene Proteins c-metIBA
03/2012 - 01/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2012 - 08/2011
2X-Linked Inhibitor of Apoptosis ProteinIBA
01/2012 - 10/2010
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
12/2011 - 07/2010
2Fatty Acids (Saturated Fatty Acids)IBA
01/2011 - 05/2010
2UbiquitinIBA
10/2009 - 05/2008
2Proteasome Endopeptidase Complex (Proteasome)IBA
10/2009 - 05/2008
2Folic Acid (Vitamin M)FDA LinkGeneric
07/2008 - 12/2007
2XenobioticsIBA
07/2008 - 01/2008
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
07/2008 - 01/2008
2Histidine (L-Histidine)FDA Link
09/2006 - 08/2006
1Cyclin-Dependent Kinase 9IBA
05/2021
1DNA HelicasesIBA
01/2021
1Carrier Proteins (Binding Protein)IBA
01/2021
1Nucleosomes (Nucleosome)IBA
01/2021
1Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA
01/2021
1Cyclin D1IBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1tyrosine receptor (receptor, tyrosine)IBA
01/2021
1Dinoprostone (PGE2)FDA Link
12/2020
1Exonucleases (3' 5' Exonuclease)IBA
01/2020
1Smad4 ProteinIBA
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2018
1olaparibIBA
12/2018
1CD34 Antigens (CD34 Antigen)IBA
10/2018
1CateninsIBA
01/2018
1F-Box ProteinsIBA
01/2018
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
09/2017
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
09/2017
1ThyroglobulinFDA Link
01/2016
1Anaplastic Lymphoma KinaseIBA
09/2015
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
06/2015
1Calcium-Calmodulin-Dependent Protein KinasesIBA
03/2015
1Histones (Histone)IBA
03/2015
1RNA Polymerase II (RNA Polymerase B)IBA
03/2015
114-3-3 Proteins (14-3-3 Protein)IBA
03/2015
1Genetic Markers (Genetic Marker)IBA
07/2014
1Mechanistic Target of Rapamycin Complex 1IBA
07/2014
1Mechanistic Target of Rapamycin Complex 2IBA
07/2014
1thymoquinoneIBA
01/2013
1Tumor Biomarkers (Tumor Markers)IBA
07/2012
1Matrix Metalloproteinases (MMPs)IBA
01/2012
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2012
1Biological ProductsIBA
07/2011
1Ubiquitin-Conjugating EnzymesIBA
05/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2011
1CyclinsIBA
05/2011
1Forkhead Box Protein M1IBA
02/2011
1Complementary DNA (cDNA)IBA
02/2011
1CaspasesIBA
01/2011

Therapy/Procedure

10Therapeutics
12/2021 - 04/2006
1Lymph Node Excision (Lymph Node Dissection)
01/2021
1Drug Therapy (Chemotherapy)
01/2013